CryoLife Inc.
CRY
Common Stock
$17.88
Sector: Health Care
Industry: Health Care Equipment & Supplies
Sub-Industry: Health Care Equipment
|
|
|
2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.44 | $0.05 | -$0.08 | $0.11 | $0.32 |
Sales/Revenue | $253.23 M | $276.22 M | $262.84 M | $189.70 M | $180.38 M |
Sales Growth | -8.32% | 5.09% | 38.55% | 5.17% | 0.00% |
Gross Margin | +60.82 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$16.57 M | $1.71 M | -$2.81 M | $3.64 M | $10.57 M |
Net Income Growth | -1070.20% | 160.72% | -177.26% | -65.55% | 0.00% |
Net Margin | -6.54 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | $30.40 M | $42.69 M | $35.81 M | $28.60 M | $30.19 M |
Cost of Goods Sold (incl D&A) | $99.21 M | $104.06 M | $100.65 M | $66.15 M | $65.91 M |
Cost of Goods Sold (excl D&A) | $71.35 M | $80.73 M | $82.55 M | $56.41 M | $57.52 M |
Cost of Goods Growth | -4.66% | 3.39% | 52.16% | 0.36% | 0.00% |
Research & Development | $24.21 M | $22.96 M | $23.10 M | $19.46 M | $13.45 M |
Other SG&A Expenses | $127.27 M | $129.84 M | $121.38 M | $85.23 M | $79.22 M |
Interest Expense | $16.82 M | $15.01 M | $15.79 M | $4.88 M | $3.04 M |
Income Tax | -$0.49 M | -$0.08 M | -$3.55 M | -$0.14 M | $7.63 M |
2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | $0.24 | -$0.06 | -$0.08 | -$0.09 |
Sales/Revenue | $72.21 M | $76.15 M | $71.09 M | $67.90 M |
Sales Growth | -5.18% | 7.12% | 4.70% | 4.25% |
Gross Margin | +60.82 | 0.00 | 0.00 | 0.00 |
Net Income | $10.52 M | -$2.16 M | -$3.12 M | -$3.44 M |
Net Income Growth | 586.09% | 30.53% | 9.45% | -20.70% |
Net Margin | -6.54 | 0.00 | 0.00 | 0.00 |
EBITDA | $4.71 M | $7.25 M | $7.36 M | $8.02 M |
Cost of Goods Sold (incl D&A) | $28.81 M | $30.03 M | $27.66 M | $27.64 M |
Cost of Goods Sold (excl D&A) | $22.80 M | $24.04 M | $21.66 M | $21.75 M |
Cost of Goods Growth | -4.05% | 8.55% | 0.09% | 8.13% |
Research & Development | $9.97 M | $8.36 M | $7.75 M | $6.57 M |
Other SG&A Expenses | $34.73 M | $36.50 M | $34.32 M | $31.56 M |
Interest Expense | $4.13 M | $4.88 M | $4.07 M | $4.72 M |
Income Tax | -$2.64 M | -$0.01 M | -$1.36 M | $3.37 M |
2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $51.65 M | $54.14 M | $31.03 M | $33.58 M | $18.50 M |
Cash and Short-Term Investment | $61.96 M | $34.29 M | $42.24 M | $40.75 M | $57.34 M |
Cash and Short-Term Investment Growth | 80.67% | -18.80% | 3.64% | -28.93% | 0.00% |
Long Term Debt | $309.80 M | $237.90 M | $221.66 M | $225.09 M | $67.02 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $789.40 M | $605.65 M | $571.09 M | $589.69 M | $316.14 M |
Total Assets Growth | 30.34% | 6.05% | -3.15% | 86.53% | 0.00% |
Inventories | $73.04 M | $53.07 M | $45.48 M | $46.68 M | $26.29 M |
Finished Goods | $33.10 M | $26.76 M | $24.24 M | $24.85 M | $13.65 M |
Short Term Debt | $7.57 M | $7.25 M | $1.89 M | $1.30 M | $4.56 M |
Total Liabilities | $460.69 M | $319.96 M | $296.02 M | $312.64 M | $107.16 M |
2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $83.89 M | $84.78 M | $70.57 M | $51.65 M | $51.24 M |
Cash and Short-Term Investment | $65.13 M | $51.03 M | $57.10 M | $61.96 M | $64.64 M |
Cash and Short-Term Investment Growth | 27.63% | -10.64% | -7.84% | -4.14% | 0.00% |
Long Term Debt | $358.14 M | $360.35 M | $353.43 M | $309.80 M | $309.93 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $818.65 M | $810.50 M | $794.83 M | $789.40 M | $782.20 M |
Total Assets Growth | 1.01% | 1.97% | 0.69% | 0.92% | 0.00% |
Inventories | $78.32 M | $76.36 M | $73.38 M | $73.04 M | $69.40 M |
Finished Goods | $31.88 M | $31.01 M | $30.86 M | $33.10 M | $31.07 M |
Short Term Debt | $5.23 M | $4.69 M | $3.30 M | $7.57 M | $7.44 M |
Total Liabilities | $507.11 M | $508.66 M | $497.50 M | $460.69 M | $456.43 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|
Quarter | Amount | Yield |
---|---|---|
2015 Q4
|
$0.03
|
1.20%
|
2015 Q3
|
$0.03
|
1.20%
|
2015 Q2
|
$0.03
|
1.10%
|
2015 Q1
|
$0.03
|
1.20%
|
2014 Q4
|
$0.03
|
1.10%
|
2014 Q3
|
$0.03
|
1.20%
|
2014 Q2
|
$0.03
|
1.30%
|
2014 Q1
|
$0.03
|
1.20%
|
2013 Q4
|
$0.03
|
1.10%
|
2013 Q3
|
$0.03
|
1.70%
|
2013 Q2
|
$0.03
|
1.60%
|
2013 Q1
|
$0.03
|
1.60%
|
2012 Q4
|
$0.03
|
1.70%
|
2012 Q3
|
$0.03
|
1.80%
|
|
|